ATLANTA, Aug. 16, 2019 /PRNewswire/ -- Today, the Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative®— announced a request for proposals (RFP) from organizations working to fight stigma, increase access to health services, and increase local leadership for

HOUSTON, Aug. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the second quarter ended June 30, 2019. Additionally, th

ORLANDO, Fla., Aug. 16, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, has updated its list of limi

SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy. The FDA gave the device a

CHICAGO, Aug. 16, 2019 /PRNewswire/ -- For the first time in its 38-year history, Chicago-based AbelsonTaylor, one of the world's premier health and wellness advertising agencies, has a new president. Founder Dale Taylor announced today that Jeff Berg, formerly executive v

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased sha

MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA's Center for Devices and Radiological Health

STOCKHOLM, Aug. 16, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the acceptance of an oral late breaking presentation providing updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study as well as two poster presentations at the 17th International Myeloma Workshop (IMW) meeting (September 12-15,

PHILADELPHIA, Aug. 16, 2019 /PRNewswire/ -- New research shows that brief parent-targeted interventions in the primary care setting can increase communication between parents and their teens about sexual and alcohol behavior. This method may serve as an important strategy for parents to influence adolescent behaviors and health outcomes.

ST. PETERSBURG, Fla., Aug. 16, 2019 /PRNewswire/ -- On April 4, 2019, the daughter of a patient who died in a Pinellas County, Florida hospital sued St. Anthony's Hospital, Inc. and Baycare Health System, Inc. The complaint alleges that the defendants were vicariously responsible for the slip and fall that ca